Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 16 articles:
HTML format
Text format



Single Articles


    July 2017
  1. DE JONG MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, Becx MC, et al
    Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial.
    Lancet. 2017 Jul 14. pii: S0140-6736(17)31327.
    PubMed     Text format     Abstract available


    May 2017
  2. LAHARIE D
    Towards therapeutic choices in ulcerative colitis.
    Lancet. 2017 May 17. pii: S0140-6736(17)31263.
    PubMed     Text format    


  3. VERMEIRE S, Sandborn WJ, Danese S, Hebuterne X, et al
    Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 May 17. pii: S0140-6736(17)30930.
    PubMed     Text format     Abstract available


  4. JORGENSEN KK, Olsen IC, Goll GL, Lorentzen M, et al
    Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.
    Lancet. 2017 May 11. pii: S0140-6736(17)30068.
    PubMed     Text format     Abstract available


    February 2017
  5. PARAMSOTHY S, Kamm MA, Kaakoush NO, Walsh AJ, et al
    Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
    Lancet. 2017 Feb 14. pii: S0140-6736(17)30182.
    PubMed     Text format     Abstract available


  6. SIEGMUND B
    Is intensity the solution for FMT in ulcerative colitis?
    Lancet. 2017 Feb 14. pii: S0140-6736(17)30313.
    PubMed     Text format    


    November 2016
  7. UNGARO R, Mehandru S, Allen PB, Peyrin-Biroulet L, et al
    Ulcerative colitis.
    Lancet. 2016 Nov 30. pii: S0140-6736(16)32126.
    PubMed     Text format     Abstract available


    September 2016
  8. CICCOCIOPPO R, Corazza GR
    Mesenchymal stem cells for fistulising Crohn's disease.
    Lancet. 2016;388:1251-2.
    PubMed     Text format    


  9. PANES J, Garcia-Olmo D, Van Assche G, Colombel JF, et al
    Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.
    Lancet. 2016;388:1281-90.
    PubMed     Text format     Abstract available


    July 2016
  10. LYNCH RW, Soane T, Gibson R, Pal S, et al
    Bilateral lower limb weakness in acute severe ulcerative colitis.
    Lancet. 2016;388:101-2.
    PubMed     Text format    


  11. STAHEL PF
    The inherent dangers of high-dose steroids for acute inflammatory conditions.
    Lancet. 2016;388:102.
    PubMed     Text format    


    February 2016
  12. KHANNA R
    Immunosuppression for management of Crohn's disease - Author's reply.
    Lancet. 2016;387:748.
    PubMed     Text format    


  13. MILOSEVIC I, Dale A, Drysdale H, Mahtani K, et al
    Immunosuppression for management of Crohn's disease.
    Lancet. 2016;387:747.
    PubMed     Text format    


  14. HERFARTH HH, Long MD, Kappelman MD
    Immunosuppression for management of Crohn's disease.
    Lancet. 2016;387:747-8.
    PubMed     Text format    


    October 2015
  15. CLEYNEN I, Boucher G, Jostins L, Schumm LP, et al
    Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.
    Lancet. 2015 Oct 16. pii: S0140-6736(15)00465.
    PubMed     Text format     Abstract available


  16. TORRES J, Colombel JF
    Genetics and phenotypes in inflammatory bowel disease.
    Lancet. 2015 Oct 16. pii: S0140-6736(15)00464.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: